Sg. Potkin et al., CLOZAPINE EFFECTS ON GLUCOSE METABOLIC-RATE IN STRIATUM AND FRONTAL-CORTEX, The Journal of clinical psychiatry, 55(9), 1994, pp. 63-66
Eighteen patients with schizophrenia had cerebral metabolic rates asse
ssed with positron emission tomography during a double-blind, placebo-
controlled crossover study of clozapine treatment. Relative metabolic
rates were increased in the basal ganglia, especially on the right sid
e. In the frontal lobe, metabolic rates were lowered, more on the left
than on the right. The anterior nuclei of the thalamus also showed lo
wer metabolic rates after clozapine. We have previously observed patie
nts with schizophrenia to have low metabolic rates in the basal gangli
a and to lack the normal right > left asymmetry; in this study, clozap
ine normalized striatal activity. In the frontal lobe, asymmetry was n
ormalized, but hypofrontal function was, if anything, exaggerated. Thi
s effect in the frontal lobe was not observed with haloperidol in earl
ier studies. The cortical effects of clozapine may be related to its u
nique clinical properties and suggest important differences between ty
pical and atypical antipsychotic drugs.